New York regulators have recalled multiple adult-use cannabis products after finding testing errors at Keystone State Testing New York, the New York State Office of Cannabis Management announced. Officials say the recall is precautionary, and no adverse health effects have been reported from consuming the products.
Inspections and a records audit conducted between December 2025 and January 2026 revealed that Keystone State Testing New York issued inaccurate results for several products. Certificates of analysis, which provide dosage and safety information to consumers, were found to be unreliable.
OCM identified 54 product lots with falsely reported results for Aspergillus, a harmful mold, and one product lot with an incorrect Cadmium reading. These findings mean some products are considered adulterated, while the safety of others remains uncertain. The errors violate New York cannabis law and regulations, officials said.
“This recall was issued after identifying problems with laboratory testing and reporting from a specific laboratory,” said Stephen Geskey, Executive Deputy Director of Licensing, Compliance and Laboratories for OCM. “When test results are inaccurate or unclear, product safety and in turn, the safety of New York State consumers cannot be guaranteed. It is not a risk OCM is willing to take.”
Dr. June Chin, OCM’s Chief Medical Officer, emphasized the recall as a public health measure. “Prompt, transparent action protects consumers and reinforces confidence in New York’s regulated cannabis market. Importantly, there have been no reported adverse health events associated with these products, and this recall reflects our proactive approach to consumer safety,” she said.
Consumers who purchased any of the affected products can return unused items to the dispensary where they were purchased.
For more information on the products recalled, click here.
